The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
Open accessAbstract
Background and aims High prevalence of diabetes makes it an important comorbidity in patients with COVID-19. We sought to review and analyze the data regarding the association between diabetes and COVID-19, pathophysiology of the disease in diabetes and management of patients with diabetes who develop COVID-19 infection. Methods PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020. Full texts of the retrieved articles were accessed. Results There is evidence of increased incidence and severity of COVID-19 in patients with diabetes. COVID-19 could have effect on the pathophysiology of diabetes. Blood glucose control is important not only for patients who are infected with COVID-19, but also for those without the disease. Innovations like telemedicine are useful to treat patients with diabetes in today’s times.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19)
Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1017 · Cited by 4,194
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“Interestingly, the prevalence of non-survivors was also higher in diabetic subjects with COVID-19 and it varied from 22 to 31% in different studies [17,21,23,24,27].”
(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
Virtually perfect? Telemedicine for COVID-19
Hollander, J. E., & Carr, B. G. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003539 · Cited by 2,970
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province
Liu, K., Fang, Y.-Y., Deng, Y., Liu, W., Wang, M.-F., Ma, J.-P., Xiao, W., Wang, Y.-N., Zhong, M.-H., Li, C.-H., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000744 · Cited by 1,411
CDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02374-0 · Cited by 1,082
Yang, J. K., Feng, Y., Yuan, M. Y., Yuan, S. Y., Fu, H. J., Wu, B. Y., Sun, G. Z., Yang, G. R., Zhang, X. L., Wang, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01861.x · Cited by 794
Badawi, A., & Ryoo, S. G. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.06.015 · Cited by 703
Comorbidities and multi-organ injuries in the treatment of COVID-19
Wang, T., Du, Z., Zhu, F., Cao, Z., An, Y., Gao, Y., & Jiang, B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30558-4 · Cited by 632
Vankadari, N., & Wilce, J. A. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1739565 · Cited by 585
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
Gupta, R., Ghosh, A., Singh, A. K., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.002 · Cited by 518
Self-citationPeng, Y., Meng, K., Guan, H., Leng, L., Zhu, R., Wang, B. Y., He, M. A., Cheng, L., Huang, K., & Zeng, Q. (2020) · PubMed · doi:10.3760/cma.j.cn112148-20200220-00105 · Cited by 469
Li, X. C., Zhang, J., & Zhuo, J. L. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.06.005 · Cited by 435
Kulcsar, K. A., Coleman, C. M., Beck, S. E., & Frieman, M. B. (2019) · JCI Insight · doi:10.1172/jci.insight.131774 · Cited by 373
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
Bozkurt, B., Kovacs, R., & Harrington, B. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.013 · Cited by 355
Gierer, S., Bertram, S., Kaup, F., Wrensch, F., Heurich, A., Krämer-Kühl, A., Welsch, K., Winkler, M., Meyer, B., Drosten, C., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00128-13 · Cited by 341
COVID-19 and diabetes: Can DPP4 inhibition play a role?
Iacobellis, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108125 · Cited by 313
Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics
Maddaloni, E., & Buzzetti, R. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3321 · Cited by 305
Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse
Roca-Ho, H., Riera, M., Palau, V., Pascual, J., & Soler, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030563 · Cited by 301
Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection
Allard, R., Leclerc, P., Tremblay, C., & Tannenbaum, T.-N. (2010) · Diabetes Care · doi:10.2337/dc09-2215 · Cited by 297
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
Yang, P., Gu, H., Zhao, Z., Wang, W., Cao, B., Lai, C., Yang, X., Zhang, L., Duan, Y., Zhang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07027 · Cited by 283
Alraddadi, B. M., Watson, J. T., Almarashi, A., Abedi, G. R., Turkistani, A., Sadran, M., Housa, A., Almazroa, M. A., Alraihan, N., Banjar, A., et al. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2201.151340 · Cited by 269
Rao, S., Lau, A., & So, H.-C. (2020) · Diabetes Care · doi:10.2337/dc20-0643 · Cited by 268
Qian, Z., Dominguez, S. R., & Holmes, K. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076469 · Cited by 242
Singh, A. K., Gupta, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.03.016 · Cited by 242
Self-citationMiddle East Respiratory Syndrome Coronavirus: A Case-Control Study of Hospitalized Patients
Al-Tawfiq, J. A., Hinedi, K., Ghandour, J., Khairalla, H., Musleh, S., Ujayli, A., & Memish, Z. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu226 · Cited by 235
Brown, N. J., Byiers, S., Carr, D., Maldonado, M., & Warner, B. A. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134197 · Cited by 231
Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality
Fernandez, C., Rysä, J., Almgren, P., Nilsson, J., Engström, G., Orho‐Melander, M., Ruskoaho, H., & Melander, O. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12783 · Cited by 211
Romaní-Pérez, M., Outeiriño-Iglesias, V., Moya, C. M., Santisteban, P., González-Matías, L. C., Vigo, E., & Mallo, F. (2015) · Endocrinology · doi:10.1210/en.2014-1685 · Cited by 178
Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
Fedson, D. S., Opal, S. M., & Rordam, O. M. (2020) · mBio · doi:10.1128/mbio.00398-20 · Cited by 173
Chen, Y., Gong, X., Wang, L., & Guo, J. (2020) · medRxiv · doi:10.1101/2020.03.25.20043133 · Cited by 153
Marney, A. M., Kunchakarra, S., Byrne, L. M., & Brown, N. J. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.156554 · Cited by 147
Rogers, L. C., Lavery, L. A., Joseph, W. S., & Armstrong, D. G. (2020) · Journal of the American Podiatric Medical Association · doi:10.7547/20-051 · Cited by 134
Leelarathna, L., English, S. W., Thabit, H., Caldwell, K., Allen, J. M., Kumareswaran, K., Wilinska, M. E., Nodale, M., Mangat, J. S., Evans, M. L., et al. (2013) · Critical Care · doi:10.1186/cc12838 · Cited by 125
Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia
Henry, C. H., Zaizafoun, M., Stock, E. M., Ghamande, S. A., Arroliga, A. C., & White, H. D. (2018) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2018.1499293 · Cited by 124
Hypertension and Diabetes Delay the Viral Clearance in COVID-19 PatientsPreprint
Chen, X., Hu, W., Ling, J., Mo, P., Zhang, Y., Jiang, Q., Ma, Z., Cao, Q., Deng, L., Song, S., et al. (2020) · medRxiv · doi:10.1101/2020.03.22.20040774 · Cited by 120
Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
Yuan, S. (2015) · mBio · doi:10.1128/mbio.01120-15 · Cited by 109
Kleine‐Weber, H., Schroeder, S., Krüger, N., Prokscha, A., Naim, H. Y., Müller, M. A., Drosten, C., Pöhlmann, S., & Hoffmann, M. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1713705 · Cited by 104
Zhang, W., Xu, Y.-Z., Liu, B., Wu, R., Yang, Y., Xiao, X., & Zhang, X. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/603409 · Cited by 98
Badawi, A. F., & Ryoo, S. G. (2016) · Journal of Public Health Research · doi:10.4081/jphr.2016.733 · Cited by 94
Kajiwara, C., Kusaka, Y., Kimura, S., Yamaguchi, T., Nanjo, Y., Ishii, Y., Udono, H., Standiford, T. J., & Tateda, K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700474 · Cited by 92
Bacterial pneumonia: comparison between diabetics and non-diabetics
Akbar, D. H. (2001) · Acta Diabetologica · doi:10.1007/s005920170017 · Cited by 78
Continuous Glucose Monitor Interference With Commonly Prescribed Medications: A Pilot Study
Basu, A., Slama, M. Q., Nicholson, W. T., Langman, L., Peyser, T., Carter, R., & Basu, R. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817697329 · Cited by 77 · cited 1×
“Though, there is some evidence of CGM interference with commonly prescribed medications like acetaminophen, atenolol and lisinopril, it has been shown to be useful and reliable in critically ill patients [67,68].”
BackgroundEFFECTS OF DIPEPTIDYL PEPTIDASE IV INHIBITION ON ARTERIAL BLOOD PRESSURE
Jackson, E. K., Dubinion, J. H., & Mi, Z. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04737.x · Cited by 69
Devin, J. K., Pretorius, M., Nian, H., Yu, C., Billings, F. T., & Brown, N. J. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02767 · Cited by 67
Ho, T., Huang, C., Tsai, Y., Lien, A. S., Lai, F., & Yu, C. (2019) · Respiratory Research · doi:10.1186/s12931-019-1035-9 · Cited by 63
Gorricho, J., Garjón, J., Alonso, Á., Celaya, M. C., Saiz, L. C., Erviti, J., & López, A. B. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13288 · Cited by 53
Razavi, Z., Maher, S., & Fredmal, J. (2018) · Endocrine · doi:10.1007/s12020-018-1635-z · Cited by 49
Zhang, M., & He, J.-Q. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02786-y · Cited by 49
Dipeptidyl peptidase-4 inhibitors can inhibit angiotensin converting enzyme
Abouelkheir, M. M., & El‐Metwally, T. H. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172638 · Cited by 35
Lee, S. W., Im, R., & Magbual, R. (2004) · Critical Care Nursing Quarterly · doi:10.1097/00002727-200404000-00009 · Cited by 28
Schuster, K. M., Barre, K., Inzucchi, S. E., Udelsman, R., & Davis, K. A. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000127 · Cited by 25
Tran, K. K., Kibert, J. L., Telford, E. D., & Franck, A. J. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019841363 · Cited by 24
Bhurayanontachai, R., Rattanaprapat, T., & Kongkamol, C. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_273_17 · Cited by 12
Cited by
Comorbidity and its Impact on Patients with COVID-19
Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00363-4 · Cited by 1,548
Dessie, Z. G., & Zewotir, T. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06536-3 · Cited by 875
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N., Singla, V., Khare, S., & Srivastava, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.044 · Cited by 776
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01582 · Cited by 581
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
John, T. M., Jacob, C. N., & Kontoyiannis, D. P. (2021) · Journal of Fungi · doi:10.3390/jof7040298 · Cited by 524
Metadata
- Authors
- Singh, A. K., Gupta, R., Ghosh, A., & Misra, A.
- Venue
- Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 14
- Issue
- 4
- Pages
- 303-310
- ISSN
- 1871-4021 (ISSN-L)
- OpenAlex
- W3015622053
- Cited by
- 893
- References
- 77
- FWCI
- 23.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.